Literature DB >> 19200414

Systematic review of the clinical effectiveness and cost-effectiveness of oesophageal Doppler monitoring in critically ill and high-risk surgical patients.

G Mowatt1, G Houston, R Hernández, R de Verteuil, C Fraser, B Cuthbertson, L Vale.   

Abstract

OBJECTIVES: To assess the effectiveness and cost-effectiveness of oesophageal Doppler monitoring (ODM) compared with conventional clinical assessment and other methods of monitoring cardiovascular function. DATA SOURCES: Electronic databases and relevant websites from 1990 to May 2007 were searched. REVIEW
METHODS: This review was based on a systematic review conducted by the US Agency for Healthcare Research and Quality (AHRQ), supplemented by evidence from any additional studies identified. Comparator interventions for effectiveness were standard care, pulmonary artery catheters (PACs), pulse contour analysis monitoring and lithium or thermodilution cardiac monitoring. Data were extracted on mortality, length of stay overall and in critical care, complications and quality of life. The economic assessment evaluated strategies involving ODM compared with standard care, PACs, pulse contour analysis monitoring and lithium or thermodilution cardiac monitoring.
RESULTS: The AHRQ report contained eight RCTs and was judged to be of high quality overall. Four comparisons were reported: ODM plus central venous pressure (CVP) monitoring plus conventional assessment vs CVP monitoring plus conventional assessment during surgery; ODM plus conventional assessment vs CVP monitoring plus conventional assessment during surgery; ODM plus conventional assessment vs conventional assessment during surgery; and ODM plus CVP monitoring plus conventional assessment vs CVP monitoring plus conventional assessment postoperatively. Five studies compared ODM plus CVP monitoring plus conventional assessment with CVP monitoring plus conventional assessment during surgery. There were fewer deaths [Peto odds ratio (OR) 0.13, 95% CI 0.02-0.96], fewer major complications (Peto OR 0.12, 95% CI 0.04-0.31), fewer total complications (fixed-effects OR 0.43, 95% CI 0.26-0.71) and shorter length of stay (pooled estimate not presented, 95% CI -2.21 to -0.57) in the ODM group. The results of the meta-analysis of mortality should be treated with caution owing to the low number of events and low overall number of patients in the combined totals. Three studies compared ODM plus conventional assessment with conventional assessment during surgery. There was no evidence of a difference in mortality (fixed-effects OR 0.81, 95% CI 0.23-2.77). Length of hospital stay was shorter in all three studies in the ODM group. Two studies compared ODM plus CVP monitoring plus conventional assessment vs CVP monitoring plus conventional assessment in critically ill patients. The patient groups were quite different (cardiac surgery and major trauma) and neither study, nor a meta-analysis, showed a statistically significant difference in mortality (fixed-effects OR 0.84, 95% CI 0.41-1.70). Fewer patients in the ODM group experienced complications (OR 0.49, 95% CI 0.30-0.81) and both studies reported a statistically significant shorter median length of hospital stay in that group. No economic evaluations that met the inclusion criteria were identified from the existing literature so a series of balance sheets was constructed. The results show that ODM strategies are likely to be cost-effective.
CONCLUSIONS: More formal economic evaluation would allow better use of the available data. All identified studies were conducted in unconscious patients. However, further research is needed to evaluate new ODM probes that may be tolerated by awake patients. Given the paucity of the existing economic evidence base, any further primary research should include an economic evaluation or should provide data suitable for use in an economic model.

Entities:  

Mesh:

Year:  2009        PMID: 19200414     DOI: 10.3310/hta13070

Source DB:  PubMed          Journal:  Health Technol Assess        ISSN: 1366-5278            Impact factor:   4.014


  8 in total

1.  Influence of size and complexity of the hospitals in an enhanced recovery programme for colorectal resection.

Authors:  Antonio Arroyo; José Manuel Ramirez; Daniel Callejo; Xavier Viñas; Sergio Maeso; Roger Cabezali; Elena Miranda
Journal:  Int J Colorectal Dis       Date:  2012-05-27       Impact factor: 2.571

2.  Enhanced recovery in colorectal surgery: a multicentre study.

Authors:  José M Ramírez; Juan A Blasco; José V Roig; Sergio Maeso-Martínez; José E Casal; Fernando Esteban; Daniel Callejo Lic
Journal:  BMC Surg       Date:  2011-04-14       Impact factor: 2.102

Review 3.  Choosing patient-tailored hemodynamic monitoring.

Authors:  Cornelis Slagt; Rose-Marieke B G E Breukers; A B Johan Groeneveld
Journal:  Crit Care       Date:  2010-03-09       Impact factor: 9.097

4.  Goal-directed fluid therapy- a survey of anaesthetists in the UK, USA, Australia and New Zealand.

Authors:  Sanket Srinivasa; Arman Kahokehr; Mattias Soop; Matthew Taylor; Andrew G Hill
Journal:  BMC Anesthesiol       Date:  2013-02-22       Impact factor: 2.217

5.  Improving surgical outcomes: it is the destination not the journey.

Authors:  Jonathan Wilson; Simon Davies
Journal:  Crit Care       Date:  2010-07-16       Impact factor: 9.097

Review 6.  Issues in the incorporation of economic perspectives and evidence into Cochrane reviews.

Authors:  Ian Shemilt; David McDaid; Kevin Marsh; Catherine Henderson; Evelina Bertranou; Jacqueline Mallander; Mike Drummond; Miranda Mugford; Luke Vale
Journal:  Syst Rev       Date:  2013-09-20

7.  A comparison of the Doppler ultrasound interpretation by student and registered podiatrists.

Authors:  Maria Young; Ivan Birch; Chloe Alexa Potter; Robert Saunders; Simon Otter; Shahin Hussain; Jane Pellett; Nadine Reynolds; Sarah Jenkin; Wendy Wright
Journal:  J Foot Ankle Res       Date:  2013-07-13       Impact factor: 2.303

8.  Cost analysis of the stroke volume variation guided perioperative hemodynamic optimization - an economic evaluation of the SVVOPT trial results.

Authors:  Jan Benes; Jan Zatloukal; Alena Simanova; Ivan Chytra; Eduard Kasal
Journal:  BMC Anesthesiol       Date:  2014-05-22       Impact factor: 2.217

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.